Reach Us +1-217-403-9671
The Danish HNPCC-System ? Biomedical Support To Individual Health Care In Here-ditary Colon Cancer Families | 8168
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

The Danish HNPCC-System ? Biomedical support to individual health care in here-ditary colon cancer families

International Conference and Exhibition on Biowaivers & Biosimilars

Inge Thomsen Bernstein

ScientificTracks Abstracts: J Bioequiv Availab

DOI: 10.4172/0975-0851.S1.002

Kelly Colletti obtained her PhD in Cellular and Molecular Biology at the University of Nevada, Reno in 2005. She is a trained herpes virologist that studied the molecular mechanisms of Cytomegalovirus and Karposi?s Sarcoma Associated Herpes Virus DNA replication. While pursuing her doctoral degree, she learned a diverse set of skills including protein expression and purification, antibody generation, enzymatic assay development, cell culture, molecular biology and protein chemistry. She also obtained an MBA during this time and has a keen business sense. Her postdoctoral fellowship was also in virology developing a reverse genetics model for the Sin Nobre Hantavirus. Kelly joined Charles River in early 2009 and has since become the lead scientist for large molecule bioanalysis and immunogenicity testing at Charles River, Preclinical Services, NV. She is also cross trained in immunotoxicology and has experience running studies in Non-Human Primates with immunophenotyping, TDAR, NK cell activity, and cytokine analysis endpoints. Since joining CRL, Kelly has participated in over 10 biosimilar programs validating bioanalytical and immunogenicity assays to support preclinical and clinical studies
Inge Bernstein is a colorectal surgeon and has completed her Ph.D from Copenhagen University and Master of Health Management from Copenhagen Business School. She is director of The Danish HNPCC-register, a National register including epidemiological and genomic data on all Danish families with Hereditary Non Polyposis Colorectal Can-cer. The aim is to improve prognosis by identifying at-risk family members, establish screening and evaluate the outcome. She has published more than 60 papers in reputed journals and is serving as an editorial board member of the Danish Colorectal Cancer Group and the InSiGHT (International Society of Gastrointestinal Hereditary Tumours).